CAR-T Therapy in China for International Patients: Costs, Access & What to Expect (2026)

China has become one of the leading destinations for CAR-T cell therapy — with approved products, shorter manufacturing timelines, and costs 50–70% below Western rates. Here is what international patients need to know.